Last reviewed · How we verify
NCT05614180: CTO-CMR
Chronic Total Occlusive Lesions CMR Study
trial testing Percutaneous coronary intervention in Chronic Total Occlusion in 400 participants. Status unknown.
1 December 2024
Quick facts
| Lead sponsor | Lin Zhao |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 20 January 2023 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Percutaneous coronary intervention
Conditions studied
- Chronic Total Occlusion — all drugs for Chronic Total Occlusion →
- Image — all drugs for Image →
- Revascularization — all drugs for Revascularization →
Sponsor
Lin Zhao — full company profile →
Who can join
Adults 18 to 80, any sex, with Chronic Total Occlusion or Image. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This registry will include consecutive patients presenting with at least one chronic total occlusion on coronary angiogram who will be treated by percutaneous coronary intervention in our center. All patients will undergo a non-invasive assessment for myocardial ischemia/viability using cardiac magnetic resonance (CMR) prior to revascularization therapy. Follow up CMR will be repeated in all participants after three months and one year. Additionally, clinical outcomes and quality of life will be evaluated at baseline and at follow-up. Primary objective of this study is to investigate the the reduction in ischemia (as evaluated by follow-up CMR) and the severity of angina according to clinical evaluation (including Seattle Angina Questionnaires \[SAQ\], Canadian Class Score\[CCS\] and 6-mins walking test).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05614180
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Percutaneous coronary intervention
Trials testing the same drug.
- NCT07349979 — PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy · NA · not yet recruiting
- NCT07457320 — Development and Validation of a Multimodal Artificial Intelligence Model for Early Prediction of Acute Myocardial Infarc · not yet recruiting
- NCT07449052 — Comprehensive Invasive Physiological Evaluation of Obstructive Coronary Artery Disease · NA · not yet recruiting
- NCT07250152 — Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction · not yet recruiting
- NCT06399705 — REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities · Phase 3 · recruiting
Other recruiting trials for Chronic Total Occlusion
Currently open trials in the same condition.
- NCT06137521 — Risk Factors and Outcomes in Coronary Chronic Total Occlusion · recruiting
Other Lin Zhao trials
Trials by the same sponsor.
- NCT07279987 — Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions · NA · not yet recruiting
- NCT07020858 — FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion · recruiting
- NCT06655922 — FAPI Imaging Assessment of Chronic Total Occlusion · recruiting
- NCT05623995 — Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO) · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05614180 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lin Zhao
- Last refreshed: 1 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05614180.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing